BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3291538)

  • 1. Urinary metabolites of thromboxane and prostacyclin in diabetes mellitus.
    Gréen K; Vesterqvist O; Grill V
    Acta Endocrinol (Copenh); 1988 Jun; 118(2):301-5. PubMed ID: 3291538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry.
    Chiabrando C; Pinciroli V; Campoleoni A; Benigni A; Piccinelli A; Fanelli R
    J Chromatogr; 1989 Oct; 495():1-11. PubMed ID: 2613794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction.
    Henriksson P; Wennmalm A; Edhag O; Vesterqvist O; Green K
    Br Heart J; 1986 Jun; 55(6):543-8. PubMed ID: 3521690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin and thromboxane in pregnant and nonpregnant women in response to exercise.
    Rauramo I; Ilmonen S; Viinikka L; Ylikorkala O
    Obstet Gynecol; 1995 Jun; 85(6):1027-30. PubMed ID: 7770249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of prostacyclin and thromboxane metabolites in threatened preterm labor: effect of indomethacin and nylidrin.
    Kurki T; Viinikka L; Ylikorkala O
    Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):150-4. PubMed ID: 1733190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetic.
    Hishinuma T; Koseki Y; Murai Y; Yamazaki T; Suzuki K; Mizugaki M
    Prostaglandins Other Lipid Mediat; 1999 Nov; 58(5-6):263-71. PubMed ID: 10593168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxane and prostacyclin formation in patients with deep vein thrombosis.
    Vesterqvist O; Gréen K; Johnsson H
    Thromb Res; 1987 Feb; 45(4):393-402. PubMed ID: 3554598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naproxen on the in vivo synthesis of thromboxane and prostacyclin in man.
    Vesterqvist O; Gréen K
    Eur J Clin Pharmacol; 1989; 37(6):563-5. PubMed ID: 2515064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo production of thromboxane and prostacyclin in patients following total hip arthroplasty.
    Vesterqvist O; Schött U; Berséus O; Axelsson K; Gréen K
    Scand J Clin Lab Invest; 1988 May; 48(3):233-9. PubMed ID: 3375779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
    Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of prostacyclin and thromboxane in man as measured by the main urinary metabolites.
    Fischer S; Bernutz C; Meier H; Weber PC
    Biochim Biophys Acta; 1986 Apr; 876(2):194-9. PubMed ID: 3754157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Evidence from measurements of the major urinary metabolite of prostacyclin by GC-MS.
    Vesterqvist O
    Eur J Clin Pharmacol; 1986; 30(1):69-73. PubMed ID: 3519239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
    Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
    Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
    Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
    Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications.
    Hishinuma T; Tsukamoto H; Suzuki K; Mizugaki M
    Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):191-6. PubMed ID: 11728171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An imbalance between the excretion of thromboxane and prostacyclin metabolites in women after the menopause.
    Jendryczko A; Tomala J
    Zentralbl Gynakol; 1993; 115(4):163-6. PubMed ID: 8503234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of unreamed and reamed intramedullary nailing on the urinary excretion of prostacyclin and thromboxane A2 metabolites in patients with tibial shaft fractures.
    Lindström T; Gullichsen E; Riutta A
    J Trauma; 1998 Oct; 45(4):743-6. PubMed ID: 9783614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A
    Mitchell JA; Knowles RB; Kirkby NS; Reed DM; Edin ML; White WE; Chan MV; Longhurst H; Yaqoob MM; Milne GL; Zeldin DC; Warner TD
    Circ Res; 2018 Feb; 122(4):555-559. PubMed ID: 29298774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence.
    Lin JS; Lui SM; Chen CM; Chang WC
    J Urol; 1992 Aug; 148(2 Pt 1):311-3. PubMed ID: 1635125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.